Tuberous sclerosis complex is associated with dysregulation of the mammalian target of rapamycin (mTOR) signaling pathway, leading to abnormal vascular smooth muscle proliferation, structural vessel wall weakness, and predisposition to aneurysm formation. The gene discussed is MTOR; the disease is tuberous sclerosis.